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ABSTRACT 
Intracranial involvement in multiple myeloma (MM) is rarely found, especially with dural involvement. There are 
only a few cases found concerning MM with intracranial involvement. MM usually involves an older group of patients. 
Cases involving young patients are very rare. The differential diagnosis of a dural plasmacytoma includes meningioma, 
metastasis, lymphoma and sarcoma of the dura mater. We present a young patient, 33 years old, with MM presenting an 
intracerebral mass mimicking meningioma on MRI. MM was diagnosed the previous year. The patient presented with 
headache, balance disturbance and back pain. MRI revealed an occipital extra-axial mass with a dural tail. 
Histopathological examination after excision showed MM. Published literatures on intracranial involvement of MM are 
also discussed. Plasmacytoma should be considered in the differential diagnosis of a solitary dural mass, particularly in a 
patient with MM. © 2009 Biomedical Imaging and Intervention Journal. All rights reserved. 
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INTRODUCTION 
Multiple myeloma (MM) is a malignant tumor that 
may involve the vertebrae and cranium. In the skull, they 
are typically multiple lytic lesions, exhibiting a ‘moth-
eaten’ appearance on radiograph [1]. The term 
plasmacytoma refers to a single lytic lesion of malignant 
plasma cells infiltration. From a classical point of view; 
intracranial plasmacytomas and MM may involve the 
cranial vault and/or the skull base only, the brain 
parenchyma, arising in the cranial vault and/or the skull 
base and the orbit [2]. However, intracranial involvement 
in plasmacytomas and MM is rare [2]. In this study, an 
intracranial mass of dural origin in a patient with one 
year history of MM is reported. Review of the literatures 
is also presented. 
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CASE REPORT 
A 33-year-old male was referred to the 
neurosurgical department by an internist with chronic 
headache. MRI study (0.5 T) performed revealed a 
posterior fossa mass. The mass was located behind the 
cerebellum, 31.3 x 31.2 x 23.0 mm in size and enhances 
post contrast (Figure 1). It has similar appearance to 
meningioma, but with a past history of MM, intracranial 
MM was considered as a differential diagnosis. 
The earlier diagnosis of MM was established by 
chance. The patient complained of back pain a year ago 
and underwent several examinations including plain 
radiographs. Several lytic lesions of the bones were 
noticed (Figure 2). Laboratory examinations performed, 
were positive for Bence Jones protein. At the time of 
referral, he had already started chemotherapy of 
capecitabine. 
He underwent surgery for the posterior fossa lesion. 
Preoperatively, the patient was fully alert and showed no 
neurological deficit. Suboccipital approach craniotomy 
was performed. Skin was incised vertically, 5 cm in 
length, in the midline between the external occipital 
protuberance and C2 process. Bone was drilled just 
below the external occipital protuberance and was 
removed so that foramen magnum was widened. 
The mass was visualized under the occipital bone, 
and it was found to have infiltrated the bone. The mass 
was grayish, soft on palpation and easily bled. After 
being cauterized from its surrounding blood supply, the 
extradural mass was removed and a small round defect 
was seen on the dura. The dura was then incised 
T-shaped and an intradural mass was visualized. Its 
appearance was similar to the extradural mass, and it had 
to be carefully cauterized before its removal from the 
surrounding structures. Arachnoid layer was perfectly 
attached and total mass removal was done. Dura was 
closed by dural plasty using fascia and the bone defect 
was left open considering that muscles in that area were 
thick enough to replace its function. 
Postoperatively, the patient was alert and showed no 
additional neurological deficit. Histopathological study 
with H&E staining demonstrated a monomorphous 
appearance of plasma cells with characteristic of round-
oval cells, eccentric nuclei, and abundant cytoplasm. 
There was also an increased nuclear to cytoplasmic ratio 
and some cells had prominent nucleoli (Figure 3). It 
confirmed a diagnosis of plasma cells tumor. 
Unfortunately, patient died within one year after the 
diagnosis of intracranial involvement of MM. 
DISCUSSION 
MM is a neoplasm of a single clone of plasma cells. 
It is characterized by proliferation of plasma cells in the 
bone marrow, infiltration of adjacent tissues with mature 
and immature plasma cells, and the production of 
immunoglobulin, usually monoclonal IgG or IgA 
(referred to collectively as M protein) [3]. Plasmacytoma 
is referred to a single lesion without any evidence of MM 
in any other part of the body [1,4]. Primary 
extramedullary plasmacytomas are uncommon, 
accounting for 4% of all plasma cell tumors, mainly 
arising in the head and neck, particularly the upper 
aerodigestive tract. Plasmacytomas generally present as 
bone or soft-tissue tumors with a variable mass effect, 
pain, and infiltrative behavior [2]. The typical clinical 
features of MM are bone pain, weakness, fatigue, fever 
and infection. 
Chiang et al in his 11 plasmacytoma-case report 
stated that solitary plasmacytoma arises from medullary 
tissue, and is believed to be an early manifestation of 
MM [5]. Within 3 to 5 years, approximately 50% of 
these tumors eventually disseminate throughout the 
skeletal system and become indistinguishable from MM. 
Patients are most commonly diagnosed during the fifth to 
sixth decade of life, and 70% are men [5]. Schwartz et al 
reported intramedullary plasmacytoma progressed to 
MM more frequently (approximately 50%) than 
extramedullary plasmacytomas (approximately 30%). 
Intracranial, calvarial lesions and most cranial base 
lesions, being intramedullary, also have a greater chance 
of progressing to MM than do dural-based lesions [6]. 
Nevertheless, one review of the literature demonstrated 
that, of 18 calvarial and 13 dural-based lesions, only 
2  calvarial lesions progressed to MM [7]. In contrast, 
Bindal et al., who presented two cranial base 
plasmacytomas and reviewed the literature on 
intracranial plasmacytomas, observed that all cranial 
base-infiltrating plasmacytomas were associated with 
MM [8]. Extracranially, MM may take several years to 
develop from a plasmacytoma [6]. 
 
Interestingly from previous literature, several reports 
were made on MM. Some mentioned the progress of 
solitary plasmacytoma into MM; others mentioned case 
reports of patients with MM and metastasized into 
intracranial lesions, whereas several reports did not put 
clear borders between the two. This patient presented to 
the authors because of a history of MM; therefore, the 
authors would like to find published reports in the 
literatures with similar appearance. By excluding those 
who were admitted with intracranial plasmacytoma as 
their first reason for admission, and excluding those who 
had no MRI and/or autopsy report confirming the 
intracranial involvement of MM, 24 cases were found 
[2,6,9-23]. Details were shown in table 1. Mean age was 
56.2 years old, with female predominance. Mean interval 
before diagnosis of intracranial involvement was 
established was 20.57 months. 90% of cases died within 
a month after diagnosis was established. 34% of those 
cases were IgG kappa MM, and 30.4% were IgG alpha. 
Petersen et al reported on 54 cases of MM with 
myelomatous meningeal involvement and a male/female 
ratio of 2:4. This type of involvement occurred more 
frequently in IgA- and IgD-MM and in Durie-Salmon 
Stage III disease. They suggested that advanced stage of 
MM observed in cases with circulating plasma cells in 
the peripheral blood showed a hematogenous spread of 
tumor cells to the meninges [20]. 
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Figure 1  MRI study demonstrated a homogenously enhanced intracranial mass of the posterior fossa. (left) 
hypointense mass on T1-weighted image, (centre) well-absorbed contrast agent on T1 with contrast 
agent, (right) note the hyperintense line in the middle of the mass of the sagittal view. 
 
 
 
Figure 2  Series of X-photo revealed osteolytic lesions. (left) AP view of the skull, (right) lateral view of the 
vertebra. 
 
 
 
Figure 3  Histopathological study of the intracranial mass, (left) monomorphous spread of plasma cell (40x), 
(right) round-oval cell with eccentric nuclei and abundant cytoplasm, and increased nuclei cytoplasm 
ratio, and mitotic phase of plasma cell. 
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Table 1  Characteristics of Multiple Myeloma Patients with Intracranial Involvement. 
Author  Cases 
Age/ 
Sex  MM type 
Lytic 
lesion  Tx 
Intracranial 
location 
Interval 
(m)  Tx  Diagnosis  Outcome  COD 
Ben-Basset (1968)  1  69/F  IgD  NR  NR  meninges NR  NR  autopsy  dead  in  16w  NR 
Maldonado (1970)  1  40/F  NR  NR  NR  meninges NR  n  autopsy  dead  in  1m  increased 
ICP 
McCarthy (1978)  1  49/M  IgG  n  cx  meninges 
frontoparietal 
12  intrathecal cx  autopsy  dead in 2w  progression 
Oda K (1990)  1  64/F  IgG K, IIIB  y  cx  meninges diffuse  36  craniospinal rx  LP, autopsy  dead in 4m  pneumonia 
Leifer D (1992)  1  67/F  IgG A  n  cx,radiation  CN 3,5,7,sup cereb 
peduncle, ffrontal 
24  intrathecal cx  MRI,CSF  dead in 2w  stroke 
Maulopoulos (1993)  2  48/F  NR  y  cx meninges  occipital  NR  NR MRI,CSF dead  in  9m  progression 
   63/M  NR  n  cx  meninges  parietal NR  resection  histology  NR  NR 
Hirata (1996)  1  43/F  IgG K  y  cx  meninges diffuse  12 intratechal  cx  MRI,CSF dead  in  1m  pneumonia 
Turhal N (1998)  1  27/M  IgG A  n  cx  sphenoclival 12  radiaton,cx  MRI,CSF  dead  sepsis 
Petersen SL (1999)  1  39/M  IgG A  y  cx  meninges  12  ntrathecal cx  MRI,CSF  dead in 9d  progression 
Roddie P (2000)  1  55/F  IgG K  y  cx  meninges,cavernous 
sinus 
12 cx  MRI  NR  NR 
Schwartz (2001)  2  49/M  IgG K  NR  radiotherapy NR  26  refused  histology  dead  progression 
   54/F  IgG  A  NR  radiotherapy NR  48  n  histology  dead  progression 
Sahin F (2004)  1  50/F  IgG K  y  cx,radiation meninges  temporal 84  resection, rx  histology  dead  progression 
Montalban (2005)  1  54/M  IgG A  y  n  sphenoclival  6 cx  MRI,histology  dead  in  9m  progression 
Haegelen C (2006)  1  72/F  IgG K  n  mass resection meninges  3  cx  MRI  dead  in  9m progression 
Jablonski (2006)  1  58/?  NR  NR  NR  meninges temporal  12  NR  MRI  NR  NR 
Tsang CS (2006)  1  61/M  IgG A  y  NR  meninges 
frontoparietal 
NR  biopsy  CT, histology  dead in 1w  progression 
Gozetti A (2007)  2  62/F  IgA K IIIA  n  cx  cavernous sinus  9  cx  MRI  dead in 8m  sepsis 
    80/F  nonsecret IIIA  n  cx  cavernous sinus  8  cx  MRI  dead (soon)  progression 
Husein OF (2007)  1  54/F  NR  NR  cx,stem cell  petrous apex,clivus  48  biopsy, rx  histology  good in 
18m 
progression 
Cerase A (2008)  3  61/F  IgG K IIIA  NR  cx,stem cell  cavernous 
sinus,clivus 
9 NR  MRI  NR  NR 
   79/F  nonsecret  IIIA  NR  cx  cavernous 
sinus,clivus 
8  palliative rx  MRI  dead (soon)  progression 
    73/F  IgG A  NR  cx (resistant)  meninges   10  NR  MRI  dead (soon)  progression 
Our case  1 33/M  NR  y  cx  meninges  occipital 12  resection  MRI,histology dead  in  1y  progression 
Total  25                               
Tx:therapy, COD: cause of death, F:female, M:Male, NR:not reported, n:none, CN:cranial nerve, cx:chemotherapy, rx:radiotherapy,  
LP:lumbar puncture, CSF:cerebrospinal fluid 
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52.2% of cases involved the cranial vault, and 
47.8% were in skull base. Of those, only 1 case involved 
the posterior fossa dura. Intracranial plasmacytoma 
involving the posterior fossa in a young patient such as 
this patient is a rare case. The authors found only 
24  cases of MM with intracranial involvement in the 
literatures, and most of them were beyond 40 years of 
age. Ishida et al reported a total of 32 cases of MM in 
patients aged 30 years and below in the literatures [24]. 
The authors' patient died within 1 year after being 
diagnosed, and most of the cases found in the literatures 
also showed short survival rates. Higurashi et al reported 
prediction indicators of progression to MM that were of 
intramedullary nature, the existence of residual tumor, 
and location in the skull base [25]. 60-70% of 
intramedullary lesions arising from the bone progress to 
MM, compared with 10% to 20% of extramedullary 
lesions arising from the soft tissues, such as the mucosal 
linings of the middle ear, mastoid air cells, and paranasal 
sinuses. Many of the skull base lesions that were initially 
considered to be solitary eventually progressed to MM 
[25]. They suggested that most plasma cell myelomas of 
the skull base are of intramedullary nature and are 
actually in the early stage of MM. On the contrary, 
plasma cell myelomas of the other cranial locations are 
mostly of extramedullary nature and appear to be solitary 
plasmacytoma [25].  
MRI study in this patient revealed a single oval 
lesion in the posterior fossa, which was enhanced 
homogenously by contrast injection, had defined border 
with cerebellum, and was located under the occipital 
bone. It appeared similar to meningioma; in addition, the 
lesion showed an enhanced line dividing the mass in half 
which was thought to be a blood supply to the 
meningioma. Plasmacytoma can be mistaken with 
meningioma since it has typical radiological features as 
an extra-axial mass with broad attachment to the dura, 
hyperdense on CT, isointense with grey matter on 
T1-weighted MRI, more variable signal intensity on 
T2-weighted MRI, and strongly and homogeneously 
enhancing with contrast [2,4,11,13,26]. During operation, 
it was revealed that the mass was located extra- and 
intradural, and that enhanced line in the middle of the 
lesion was actually the dura itself. Sahin et al found that 
intracranial plasmacytomas are usually highly vascular 
and pathological vessels and a tumor blush may be seen 
on angiography. However, the majority of dural or 
intraparenchymal plasmacytomas are less vascular and 
angiography may be normal. Therefore, angiography is 
not reliable for differential diagnosis, as 30-50% of 
meningiomas may also be associated with normal 
angiography [18]. Radiological ﬁndings of intracranial 
MM or plasmacytoma are not speciﬁc. They may mimic 
lymphoma, metastasis, sarcoma of the dura mater, 
osteochondroma, infectious meningitis or meningioma 
[27,28]. The authors also examined the mass 
histopathologically. The mass revealed monomorphous 
plasma cells, which were in accordance with his history 
of MM. Dural origin mass and bone-attached mass were 
both examined. Both pointed out the same type of cells. 
In conclusion, despite its systemic manifestation, 
MM may appear as intracranial mass. Although dural 
inﬁltration is very rare, it should be considered in the 
differential diagnosis, particularly if a solitary 
intracranial mass with typical features of meningioma is 
detected on MRI. Its origin and MRI appearance should 
be carefully observed before performing surgery. 
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